Song Youn Park

Assistant Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Song Youn Park is an Assistant Professor at the University of Washington in the United States. His research primarily focuses on Merkel cell carcinoma, exploring topics such as immunotherapy responses in immunosuppressed patients, circulating tumor DNA assays, and the implications of autoimmune disorders in prognosis. His recent publications highlight significant advancements in understanding the treatment and detection of Merkel cell carcinoma, particularly in the context of immunotherapy and disease progression.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Andre Berndt

Assistant Professor

University of Washington

UNITED STATES

View details

Lisa C Zaba

Stanford University School of Medicine

UNITED STATES

View details

Ann Silk

Dana-Farber Cancer Institute

UNITED STATES

View details

Tomoko Akaike

Assistant professor

University of Washington

UNITED STATES

View details

Paul Nghiem

Professor

University of Washington

UNITED STATES

View details

Shailender Bhatia

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Kimberly Smythe

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Song Youn Park

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients

Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications

Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy

Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma

Unmasking hidden Merkel cell carcinoma recurrences: Three illustrative cases of patients with rising viral oncoprotein antibody levels and challenge of requiring multi-modal imaging to detect clinical disease

Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes

Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patients

Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma

Tumoral melanosis mimicking residual melanoma in the setting of talimogene laherparepvec treatment

How we treat Merkel cell carcinoma: within and beyond current guidelines.

Collaborators (7)

Andre Berndt

Lisa C Zaba

Ann Silk

Tomoko Akaike

Paul Nghiem

Shailender Bhatia

Kimberly Smythe

Make your next move.